House Representatives begin investigation into MS drug pricing

18-08-2017

Two US House Representatives have begun an investigation into the pricing of drugs used to treat multiple sclerosis (MS).


House of Representatives, pharmaceuticals, big pharma, multiple sclerosis, pricing, Bayer, Biogen, Novartis, Sanofi, Teva, Roche, EMD Serono

LSIPR